139 related articles for article (PubMed ID: 38387812)
21. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric and radiobiological comparison of IMRT, VMAT, and helical tomotherapy planning techniques in hippocampal sparing whole brain radiotherapy with simultaneous integrated boost for multiple brain metastases.
Balasubramanian S; Shobana MK; Anabalagan D; Thanasekar P; Joel S; Chaudhary P
Radiat Environ Biophys; 2024 Mar; 63(1):47-57. PubMed ID: 38194100
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.
Soltys SG; Milano MT; Xue J; Tomé WA; Yorke E; Sheehan J; Ding GX; Kirkpatrick JP; Ma L; Sahgal A; Solberg T; Adler J; Grimm J; El Naqa I
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):100-111. PubMed ID: 33375955
[TBL] [Abstract][Full Text] [Related]
24. Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer.
Hernández TG; González AV; Peidro JP; Ferrando JV; González LB; Cabañero DG; Torrecilla JL
Rep Pract Oncol Radiother; 2013; 18(5):265-71. PubMed ID: 24416563
[TBL] [Abstract][Full Text] [Related]
25. Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study.
Ong ALK; Knight K; Panettieri V; Dimmock M; Tuan JKL; Tan HQ; Wright C
Front Oncol; 2023; 13():1241711. PubMed ID: 38023170
[TBL] [Abstract][Full Text] [Related]
26. Focal dose escalation for prostate cancer using
Zamboglou C; Thomann B; Koubar K; Bronsert P; Krauss T; Rischke HC; Sachpazidis I; Drendel V; Salman N; Reichel K; Jilg CA; Werner M; Meyer PT; Bock M; Baltas D; Grosu AL
Radiat Oncol; 2018 May; 13(1):81. PubMed ID: 29716617
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
[TBL] [Abstract][Full Text] [Related]
28. Inhomogeneous target-dose distributions: a dimension more for optimization?
De Gersem WR; Derycke S; Colle CO; De Wagter C; De Neve WJ
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):461-8. PubMed ID: 10760444
[TBL] [Abstract][Full Text] [Related]
29. Robust dose-painting-by-numbers vs. nonselective dose escalation for non-small cell lung cancer patients.
Petit SF; Breedveld S; Unkelbach J; den Hertog D; Balvert M
Med Phys; 2021 Jun; 48(6):3096-3108. PubMed ID: 33721350
[TBL] [Abstract][Full Text] [Related]
30. Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.
Murray LJ; Lilley J; Thompson CM; Cosgrove V; Mason J; Sykes J; Franks K; Sebag-Montefiore D; Henry AM
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):406-15. PubMed ID: 24685447
[TBL] [Abstract][Full Text] [Related]
31. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
Song W; Battista J; Van Dyk J
Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
[TBL] [Abstract][Full Text] [Related]
32. Image-guided adaptive radiation therapy (IGART): Radiobiological and dose escalation considerations for localized carcinoma of the prostate.
Song W; Schaly B; Bauman G; Battista J; Van Dyk J
Med Phys; 2005 Jul; 32(7):2193-203. PubMed ID: 16121573
[TBL] [Abstract][Full Text] [Related]
33. Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients.
Kok HP; Herrera TD; Crezee J
Strahlenther Onkol; 2024 Jun; 200(6):512-522. PubMed ID: 38177701
[TBL] [Abstract][Full Text] [Related]
34. Can reduction of uncertainties in cervix cancer brachytherapy potentially improve clinical outcome?
Nesvacil N; Tanderup K; Lindegaard JC; Pötter R; Kirisits C
Radiother Oncol; 2016 Sep; 120(3):390-396. PubMed ID: 27452410
[TBL] [Abstract][Full Text] [Related]
35. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
37. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
38. Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging.
Zaider M; Zelefsky MJ; Lee EK; Zakian KL; Amols HI; Dyke J; Cohen G; Hu Y; Endi AK; Chui C; Koutcher JA
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1085-96. PubMed ID: 10863082
[TBL] [Abstract][Full Text] [Related]
39. Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference.
Spohn SKB; Sachpazidis I; Wiehle R; Thomann B; Sigle A; Bronsert P; Ruf J; Benndorf M; Nicolay NH; Sprave T; Grosu AL; Baltas D; Zamboglou C
Front Oncol; 2021; 11():652678. PubMed ID: 34055621
[TBL] [Abstract][Full Text] [Related]
40. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
